Unity Biotechnology (STU:9U90) Operating Cash Flow per Share : €-1.89 (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Operating Cash Flow per Share?

Unity Biotechnology's operating cash flow per share for the three months ended in Mar. 2024 was €-0.28. Unity Biotechnology's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.89.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 45.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 33.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Unity Biotechnology's Operating Cash Flow per Share or its related term are showing as below:

STU:9U90' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 26.1 Med: 30.7 Max: 48.3
Current: 45.4

During the past 8 years, Unity Biotechnology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 48.30% per year. The lowest was 26.10% per year. And the median was 30.70% per year.

STU:9U90's 3-Year OCF Growth Rate is ranked better than
89.25% of 1237 companies
in the Biotechnology industry
Industry Median: 3.6 vs STU:9U90: 45.40

Unity Biotechnology Operating Cash Flow per Share Historical Data

The historical data trend for Unity Biotechnology's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Operating Cash Flow per Share Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-14.94

-12.66

-7.14

-5.21

-2.30

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.74	-0.71	-0.46	-0.44	-0.28

Competitive Comparison of Unity Biotechnology's Operating Cash Flow per Share

For the Biotechnology subindustry, Unity Biotechnology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unity Biotechnology's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Unity Biotechnology's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Unity Biotechnology's Price-to-Operating-Cash-Flow falls into.

Unity Biotechnology Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Unity Biotechnology's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-34.01	/	14.774
	=	-2.30

Unity Biotechnology's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-4.768	/	16.785
	=	-0.28

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.89

Unity Biotechnology Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines